Growth Metrics

Omeros (OMER) Assets Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.69%
Dec 31, 2025 17.52%
Sep 30, 2025 -40.73%
Jun 30, 2025 -43.71%
Mar 31, 2025 -46.25%
Dec 31, 2024 -26.75%
Sep 30, 2024 -36.45%
Jun 30, 2024 -32.44%
Mar 31, 2024 -21.89%
Dec 31, 2023 -35.99%
Sep 30, 2023 7.76%
Jun 30, 2023 52.59%
Mar 31, 2023 51.69%
Dec 31, 2022 40.95%
Sep 30, 2022 270.70%
Jun 30, 2022 137.73%
Mar 31, 2022 128.73%
Dec 31, 2021 131.59%
Sep 30, 2021 -45.64%
Jun 30, 2021 105.68%
Mar 31, 2021 36.57%
Dec 31, 2020 32.18%
Sep 30, 2020 148.81%
Jun 30, 2020 -21.25%
Mar 31, 2020 16.76%
Dec 31, 2019 42.77%
Sep 30, 2019 20.70%
Jun 30, 2019 -15.60%
Mar 31, 2019 13.71%
Dec 31, 2018 -17.53%
Sep 30, 2018 -39.76%
Jun 30, 2018 76.21%
Mar 31, 2018 52.45%
Dec 31, 2017 72.91%
Sep 30, 2017 72.50%
Jun 30, 2017 30.90%
Mar 31, 2017 62.36%
Dec 31, 2016 37.32%
Sep 30, 2016 75.68%
Jun 30, 2016 -21.37%
Mar 31, 2016 -51.98%
Dec 31, 2015 352.23%
Sep 30, 2015 63.74%
Jun 30, 2015 43.04%
Mar 31, 2015 33.61%
Dec 31, 2014 -34.48%
Sep 30, 2014 110.54%
Jun 30, 2014 77.78%
Mar 31, 2014 216.89%
Dec 31, 2013 -37.78%
Sep 30, 2013 -63.33%
Jun 30, 2013 129.07%
Mar 31, 2013 -16.10%
Dec 31, 2012 -1.51%
Sep 30, 2012 -6.35%
Jun 30, 2012 -75.42%
Dec 31, 2011 -40.96%